Wu et al. found that SPINT1 was upregulated in breast cancer and relatively higher in HER-2-enriched and node positive patients, and the functional enrichment analysis showed that the co-expressed SPINT1 and SPINT2 expression were primarily involved in modulating cell attachment and migration [69]. Here, SPINT2 is linked to breast cancer.